Literature DB >> 20138013

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

Pauline Andreu1, Magnus Johansson, Nesrine I Affara, Ferdinando Pucci, Tingting Tan, Simon Junankar, Lidiya Korets, Julia Lam, David Tawfik, David G DeNardo, Luigi Naldini, Karin E de Visser, Michele De Palma, Lisa M Coussens.   

Abstract

Chronically activated leukocytes recruited to premalignant tissues functionally contribute to cancer development; however, mechanisms underlying pro- versus anti-tumor programming of neoplastic tissues by immune cells remain obscure. Using the K14-HPV16 mouse model of squamous carcinogenesis, we report that B cells and humoral immunity foster cancer development by activating Fcgamma receptors (FcgammaRs) on resident and recruited myeloid cells. Stromal accumulation of autoantibodies in premalignant skin, through their interaction with activating FcgammaRs, regulate recruitment, composition, and bioeffector functions of leukocytes in neoplastic tissue, which in turn promote neoplastic progression and subsequent carcinoma development. These findings support a model in which B cells, humoral immunity, and activating FcgammaRs are required for establishing chronic inflammatory programs that promote de novo carcinogenesis. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138013      PMCID: PMC3082507          DOI: 10.1016/j.ccr.2009.12.019

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  40 in total

1.  Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies.

Authors:  E Barbera-Guillem; K F May; J K Nyhus; M B Nelson
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 2.  Mast cells: the Jekyll and Hyde of tumor growth.

Authors:  Theoharis C Theoharides; Pio Conti
Journal:  Trends Immunol       Date:  2004-05       Impact factor: 16.687

3.  Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.

Authors:  U Baumann; N Chouchakova; B Gewecke; J Köhl; M C Carroll; R E Schmidt; J E Gessner
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

4.  B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion.

Authors:  E Barbera-Guillem; M B Nelson; B Barr; J K Nyhus; K F May; L Feng; J W Sampsel
Journal:  Cancer Immunol Immunother       Date:  2000-01       Impact factor: 6.968

Review 5.  Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer.

Authors:  Angus G Dalgleish; Ken J O'Byrne
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

6.  A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice.

Authors:  M F Lyon; P H Glenister
Journal:  Genet Res       Date:  1982-06       Impact factor: 1.588

7.  MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

Authors:  L M Coussens; C L Tinkle; D Hanahan; Z Werb
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

8.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

Authors:  Enrico Giraudo; Masahiro Inoue; Douglas Hanahan
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 9.  A review of the current use of rituximab in autoimmune diseases.

Authors:  Hakan M Gürcan; Derin B Keskin; Joel N H Stern; Matthew A Nitzberg; Haris Shekhani; A Razzaque Ahmed
Journal:  Int Immunopharmacol       Date:  2008-11-08       Impact factor: 4.932

10.  Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein.

Authors:  C T Siegel; K Schreiber; S C Meredith; G B Beck-Engeser; D W Lancki; C A Lazarski; Y X Fu; D A Rowley; H Schreiber
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  235 in total

Review 1.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

Review 4.  Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states.

Authors:  Lionel B Ivashkiv
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

5.  Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.

Authors:  Andrew J Gunderson; Megan M Kaneda; Takahiro Tsujikawa; Abraham V Nguyen; Nesrine I Affara; Brian Ruffell; Sara Gorjestani; Shannon M Liudahl; Morgan Truitt; Peter Olson; Grace Kim; Douglas Hanahan; Margaret A Tempero; Brett Sheppard; Bryan Irving; Betty Y Chang; Judith A Varner; Lisa M Coussens
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

6.  Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.

Authors:  Kyoung Eun Lee; Michelle Spata; Lauren J Bayne; Elizabeth L Buza; Amy C Durham; David Allman; Robert H Vonderheide; M Celeste Simon
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

7.  Cancer: Fibroblasts for all seasons.

Authors:  Erwin F Wagner
Journal:  Nature       Date:  2016-02-04       Impact factor: 49.962

8.  Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.

Authors:  Andrew H Ko; Alexander C Jordan; Evan Tooker; Simon F Lacey; Renee B Chang; Yan Li; Alan P Venook; Margaret Tempero; Lloyd Damon; Lawrence Fong; Mark H O'Hara; Bruce L Levine; J Joseph Melenhorst; Gabriela Plesa; Carl H June; Gregory L Beatty
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

Review 9.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

Review 10.  B cells and their mediators as targets for therapy in solid tumors.

Authors:  Andrew J Gunderson; Lisa M Coussens
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.